QURE uniQure N.V. - Ordinary Shares
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Tem 29, 2026
$23,46
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$8,7352 haftanın en düşüğü
$71,5052 haftanın en yükseği
Piyasa Değeri (MRQ)
$1.63B
P/E (TTM)
-5.8
Hisse Başına Kâr (TTM)
$-4.02
Gelir (TTM)
$19M
rozetleriniz
52 Haftlık Aralık
$9–$72
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$65
P/E
-5.8
ROE
-157.6%
Net Kâr Marjı
-1350.7%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
QURE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$23.46
Piyasa Değeri (MRQ)
$1.63B
P/E (TTM)
-5.8
Hisse Başına Kâr (TTM)
$-4.02
Gelir (TTM)
$19M
ROE (TTM)
-157.6%
D/E Borç/Özsermaye (MRQ)
0.2
52 Haftlık Aralık
$9–$72
QURE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$16M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-3.462019-12-31 → 2025-12-31
Serbest Nakit Akışı$-178M2016-12-31 → 2025-12-31
Net kar marjı-1350.7%2017-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | QURE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -5.85Y ort. ≈-3.4 | ≈-3.4 | · | · | |
| F/S (TTM) | 87.15Y ort. ≈31.4 | ≈31.4 | · | · | |
| F/D (MRQ) | 5.05Y ort. ≈-23.0 | ≈-23.0 | · | · | |
| EV / EBITDA | -7.85Y ort. ≈-3.5 | ≈-3.5 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -10.15Y ort. ≈-3.6 | ≈-3.6 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -10.15Y ort. ≈-3.9 | ≈-3.9 | · | · | |
| EV / Revenue (EV / Gelir) | 90.05Y ort. ≈28.0 | ≈28.0 | · | · | |
| EV / FCF | -8.15Y ort. ≈-3.5 | ≈-3.5 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 6.25Y ort. ≈5.5 | ≈5.5 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | QURE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -1071.5%5Y ort. ≈-738.3% | ≈-738.3% | · | · | |
| EBITDA Margin (FAVÖK Marjı) | -1151.4%5Y ort. ≈-738.3% | ≈-738.3% | · | · | |
| Vergi Öncesi Kar Marjı (TTM) | -1313.0%5Y ort. ≈-813.5% | ≈-813.5% | · | · | |
| Net Kâr Marjı (TTM) | -1350.7%5Y ort. ≈-824.5% | ≈-824.5% | · | · | |
| ROA (TTM) | -32.1%5Y ort. ≈-12.6% | ≈-12.6% | · | · | |
| ROE (TTM) | -157.6%5Y ort. ≈-256.6% | ≈-256.6% | · | · | |
| ROIC | -76.7%5Y ort. ≈-113.3% | ≈-113.3% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | QURE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.25Y ort. ≈-1.3 | ≈-1.3 | · | · | |
| Cari Oran (MRQ) | 10.05Y ort. ≈10.5 | ≈10.5 | · | · | |
| Quick Ratio (Cari Oran) | 1.35Y ort. ≈5.3 | ≈5.3 | · | · | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 0.25Y ort. ≈-1.3 | ≈-1.3 | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | QURE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -40.6%5Y ort. ≈232.5% | ≈232.5% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -46.7%5Y ort. ≈-44.8% | ≈-44.8% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | -15.6% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | QURE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.2 | ≈0.2 | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$72.8K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-2.1%
Sonraki Rapor
Kas 09, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | $-1.22 | $-0.84 | -45.1% | |
| 31 Mart 2026 | May 12, 2026 | $-0.85 | $-0.89 | 4.9% |
| 31 Aralık 2025 | $-0.64 | $-0.97 | 33.7% | |
| 30 Eylül 2025 | $-1.38 | $-0.92 | -50.4% | |
| 30 Haziran 2025 | $-0.69 | $-0.91 | 24.4% | |
| 31 Mart 2025 | $-0.82 | $-1.03 | 20.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $27M | $16M | $106M | $524M | $38M | $7M | $11M | $13M | $25M | $11M | |
| Cost of Revenue | $2M | $1M | $65.0K | $1M | $25M | $3M | $2M | $1M | $817.0K | $1M | · | |
| R&D Expense | $141M | $144M | $215M | $198M | $144M | $122M | $95M | $75M | $72M | $73M | $59M | |
| SG&A Expense | $65M | $53M | $75M | $55M | $56M | $43M | $34M | $25M | $25M | $26M | $23M | |
| Operating Expenses | $208M | $215M | $303M | $256M | $225M | $165M | $128M | $100M | $97M | $99M | $83M | |
| Operating Income | $-185M | $-184M | $-283M | $-143M | $311M | $-125M | $-121M | $-88M | $-71M | $-72M | $-71M | |
| Interest Expense | · | · | $42M | $12M | $7M | $4M | $4M | $2M | $2M | $2M | $3M | |
| Interest Income | $17M | $21M | $20M | $609.0K | $162.0K | $938.0K | $4M | $3M | $117.0K | $70.0K | $121.0K | |
| Other Non-op | $11M | · | · | $3M | $-160.0K | $483.0K | $-3M | $208.0K | $-2M | $785.0K | $-7M | |
| Pretax Income | $-193M | $-237M | $-307M | $-128M | $333M | $-141M | $-124M | $-83M | $-79M | $-72M | $-83M | |
| Income Tax | $6M | $2M | $2M | $-1M | $3M | $-16M | · | $231.0K | $-199.0K | $1M | $-1M | |
| Net Income | $-199M | $-240M | $-308M | $-127M | $330M | $-125M | $-124M | $-83M | $-79M | $-73M | $-82M | |
| EPS (Basic) | $-3.46 | $-4.92 | $-6.47 | $-2.71 | $7.17 | $-2.81 | $-3.11 | · | · | · | · | |
| EPS (Diluted) | $-3.46 | $-4.92 | $-6.47 | $-2.71 | $7.04 | $-2.81 | $-3.11 | · | · | · | · | |
| Shares (Basic) | 57,502,068 | 48,649,129 | 47,670,986 | 46,735,045 | 45,986,467 | 44,466,365 | 39,999,450 | · | · | · | · | |
| Shares (Diluted) | 57,502,068 | 48,649,129 | 47,670,986 | 46,735,045 | 46,840,972 | 44,466,365 | 39,999,450 | · | · | · | · | |
| EBITDA | $-185M | $-184M | $-283M | $-143M | $311M | $-125M | $-121M | · | $-71M | $-72M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $80M | $159M | $241M | $228M | $556M | $245M | $378M | $235M | $159M | $132M | $222M | |
| Receivables | $6M | · | · | · | · | $7M | · | · | · | $4M | · | |
| Inventory | · | · | $12M | $7M | · | · | · | · | · | · | $474.0K | |
| Prepaid Expense | $21M | $9M | $15M | $12M | $11M | $4M | $5M | $1M | $1M | $996.0K | $690.0K | |
| Other Current Assets | · | · | · | · | · | $3M | $748.0K | $329.0K | $687.0K | $1M | $1M | |
| Current Assets | $656M | $390M | $652M | $477M | $628M | $259M | $384M | $237M | $163M | $144M | $228M | |
| PP&E (Net) | $14M | $20M | $47M | $51M | $44M | $32M | $29M | $29M | $34M | $36M | $26M | |
| PP&E (Gross) | $58M | $52M | $102M | $95M | $80M | $68M | $57M | $52M | $51M | $48M | $37M | |
| Accum. Depreciation | $44M | $32M | $56M | $44M | $37M | $35M | $29M | $23M | $17M | $12M | $11M | |
| Goodwill | $25M | $22M | $26M | $26M | $28M | $542.0K | $496.0K | $506.0K | $530.0K | $465.0K | $481.0K | |
| Intangibles | $73M | $71M | $60M | $59M | $63M | $3M | $5M | $5M | $10M | $8M | $7M | |
| Other Non-current Assets | $6M | $1M | $3M | $6M | $6M | $3M | · | · | $2M | $2M | $1M | |
| Total Assets | $825M | $557M | $832M | $705M | $809M | $340M | $449M | $274M | $210M | $190M | $263M | |
| Accounts Payable | $5M | $7M | $7M | $11M | $3M | $4M | $6M | $4M | $3M | $6M | $4M | |
| Accrued Liabilities | $41M | $29M | $31M | $31M | $28M | $18M | $12M | $8M | · | · | · | |
| Current Liabilities | $63M | $40M | $74M | $76M | $37M | $27M | $32M | $20M | $19M | $23M | $27M | |
| Capital Leases | $10M | $11M | $28M | $32M | $29M | $30M | $31M | · | · | · | · | |
| Deferred Tax | $8M | $7M | $8M | $8M | $13M | · | · | · | · | · | · | |
| Other Non-current Liabilities | $4M | $8M | $4M | $935.0K | $4M | $3M | $534.0K | $435.0K | $614.0K | $51.0K | $578.0K | |
| Total Liabilities | $626M | $563M | $624M | $229M | $213M | $96M | $126M | $94M | $120M | $127M | $135M | |
| Long-term Debt | $72M | $66M | $148M | $144M | $136M | $42M | $47M | $48M | $24M | $20M | $20M | |
| Total Debt | $50M | $51M | $102M | $103M | $101M | $36M | $36M | · | $21M | $20M | · | |
| Common Stock | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Paid-in Capital | $1.58B | $1.17B | $1.15B | $1.11B | $1.08B | $1.02B | $987M | $720M | $567M | $465M | $456M | |
| Retained Earnings | $-1.33B | $-1.13B | $-890M | $-582M | $-455M | $-785M | $-660M | $-536M | $-475M | $-396M | $-323M | |
| AOCI | $-58M | $-53M | $-54M | $-58M | $-29M | $-10M | $-7M | $-7M | $-4M | $-7M | $-7M | |
| Stockholders' Equity | $199M | $-7M | $208M | $476M | $596M | $244M | $323M | $180M | $89M | $64M | $128M | |
| Liabilities + Equity | $825M | $557M | $832M | $705M | $809M | $340M | $449M | $274M | $210M | $190M | $263M | |
| Shares Outstanding | 62,336,717 | 48,988,087 | 47,833,830 | 46,968,032 | 46,298,635 | 44,777,799 | 43,711,954 | 37,351,653 | 31,339,040 | 25,257,420 | 24,327,944 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $13M | $12M | $9M | $7M | $11M | $7M | $12M | $8M | · | · | |
| Stock-based Comp | $18M | $22M | $35M | $34M | $26M | $22M | $18M | $11M | $10M | $6M | $12M | |
| Deferred Tax | $2M | $2M | $2M | $-1M | $3M | $-16M | · | $209.0K | $-209.0K | $1M | $-1M | |
| Restructuring | · | · | $3M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-178M | $-183M | $-146M | $-145M | $288M | $-135M | $-99M | $-76M | $-64M | $-72M | $7M | |
| CapEx | $439.0K | $3M | $7M | $18M | $17M | $7M | $6M | $2M | $4M | $15M | $8M | |
| Investing Cash Flow | $-322M | $163M | $-206M | $-183M | $-67M | $-9M | $-7M | $-4M | $-6M | $-17M | $-8M | |
| Debt Issued | · | · | · | · | $64M | · | · | $15M | · | · | · | |
| Net Debt Issued | · | $-53M | · | · | $64M | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | $31M | $7M | $6M | $5M | $4M | $3M | $3M | |
| Net Stock Activity | · | · | · | · | $3M | $7M | $6M | · | $4M | $3M | · | |
| Financing Cash Flow | $415M | $-59M | $363M | $1M | $95M | $7M | $249M | $158M | $90M | $2M | $161M | |
| Net Change in Cash | $-79M | $-84M | $13M | $-328M | $312M | $-133M | $143M | $75M | $28M | $-89M | $157M | |
| Taxes Paid | $8M | $21.0K | $12.0K | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-178M | $-186M | $-153M | $-163M | $271M | $-142M | $-104M | · | $-69M | $-87M | · | |
| Levered FCF | · | · | $-195M | $-174M | $263M | $-145M | · | · | $-71M | $-90M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1151.4% | -679.6% | -1785.5% | -134.4% | 59.3% | -334.3% | -1663.8% | · | -544.3% | -286.7% | · | |
| Net Margin | -1236.0% | -883.4% | -1947.1% | -119.1% | 62.9% | -333.3% | -1705.8% | · | -604.7% | · | · | |
| Pretax Margin | -1201.0% | -874.4% | -1935.0% | -120.4% | 63.5% | -377.0% | -1705.8% | · | -606.2% | -287.8% | · | |
| EBITDA Margin | -1151.4% | -679.6% | -1785.5% | -134.4% | 59.3% | -334.3% | -1663.8% | · | -544.3% | -286.7% | · | |
| ROA | -28.8% | -34.5% | -40.2% | -16.8% | 57.3% | -31.7% | -34.4% | · | -39.6% | · | · | |
| ROE | -204.2% | -976.4% | -129.5% | -28.3% | 55.6% | -53.0% | -36.9% | · | -103.6% | · | · | |
| ROIC | -76.7% | -417.7% | -92.0% | -24.4% | 44.1% | -39.7% | · | · | -64.6% | -87.2% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.4 | 9.7 | 8.8 | 6.3 | 17.1 | 9.5 | 12.1 | · | 8.5 | 6.3 | · | |
| Quick Ratio | 1.3 | 4.0 | 3.3 | 3.0 | 15.1 | 9.2 | 11.9 | · | 8.3 | 6.0 | · | |
| Debt / Equity | 0.2 | -7.6 | 0.5 | 0.2 | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.3 | · | |
| LT Debt / Equity | 0.2 | -7.6 | 0.5 | 0.2 | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.3 | · | |
| Interest Coverage | · | · | -6.8 | -12.2 | 41.6 | -32.8 | -31.8 | · | -32.0 | -33.1 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.1 | 0.9 | 0.1 | 0.0 | · | 0.1 | 0.1 | · | |
| Inventory Turnover | · | · | 0.0 | 0.3 | · | · | · | · | · | · | · | |
| Receivables Turnover | · | · | · | · | · | 7.3 | · | · | · | 13.6 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.19 | $-0.14 | $4.34 | $10.13 | $12.87 | $5.45 | $7.39 | · | $2.85 | $2.52 | · | |
| Revenue / Share | $0.28 | $0.56 | $0.33 | $2.28 | $11.19 | · | · | · | · | · | · | |
| Cash Flow / Share | $-3.09 | $-3.76 | $-3.06 | $-3.10 | $6.15 | · | · | · | · | · | · | |
| Cash / Share | $1.29 | $3.24 | $5.05 | $4.85 | $12.01 | $5.47 | $8.64 | · | $5.09 | $5.25 | · | |
| EPS (TTM) | $-3.46 | $-4.92 | $-6.47 | $-2.71 | $7.04 | $-2.81 | $-3.11 | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -40.6% | 71.2% | -85.1% | -79.7% | 1296.8% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -46.7% | -62.7% | -25.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -15.6% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $16M | $27M | $16M | $106M | $524M | $38M | $7M | $11M | $13M | $25M | · | |
| Net Income TTM | $-199M | $-240M | $-308M | $-127M | $330M | $-125M | $-124M | $-83M | $-79M | $-73M | · | |
| Market Cap | $1.49B | $865M | $324M | $1.06B | $960M | $1.62B | $3.13B | · | $614M | $141M | · | |
| Enterprise Value | $1.46B | $758M | $184M | $940M | $505M | $1.41B | $2.79B | · | $475M | $29M | · | |
| P/E | -6.9 | -3.6 | -1.0 | -8.4 | 2.9 | -12.9 | -23.0 | · | · | · | · | |
| P/S | 92.7 | 31.9 | 20.4 | 10.0 | 1.8 | 43.1 | 430.2 | · | 46.8 | 5.6 | · | |
| P/B | 7.5 | -128.1 | 1.6 | 2.2 | 1.6 | 6.6 | 9.7 | · | 6.9 | 2.2 | · | |
| P / Tangible Book | 14.8 | · | 2.7 | 2.7 | 1.9 | 6.7 | · | · | · | · | · | |
| P / Cash Flow | -8.4 | -4.7 | -2.2 | -7.3 | 3.3 | -12.0 | -31.7 | · | -9.6 | -2.0 | · | |
| P / FCF | -8.4 | -4.6 | -2.1 | -6.5 | 3.5 | -11.4 | -30.0 | · | -8.9 | -1.6 | · | |
| EV / EBITDA | -7.9 | -4.1 | -0.7 | -6.6 | 1.6 | -11.2 | -23.0 | · | -6.7 | -0.4 | · | |
| EV / FCF | -8.2 | -4.1 | -1.2 | -5.8 | 1.9 | -9.9 | -26.7 | · | -6.9 | -0.3 | · | |
| EV / Revenue | 90.8 | 27.9 | 11.6 | 8.8 | 1.0 | 37.5 | 383.3 | · | 36.3 | 1.2 | · | |
| Earnings Yield | -14.5% | -27.9% | -95.6% | -11.9% | 33.9% | -7.8% | -4.3% | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $4M | $6M | $4M | $5M | $2M | $5M | $2M | $11M | $8M | $7M | $1M | $2M | $5M | $103M | $1M | |
| Cost of Revenue | $350.0K | $219.0K | $435.0K | $398.0K | $656.0K | $197.0K | $619.0K | $264.0K | $234.0K | $150.0K | · | · | · | · | · | · | |
| R&D Expense | $34M | $29M | $35M | $34M | $35M | $36M | $39M | $31M | $34M | $41M | $43M | $65M | $46M | $61M | $58M | $48M | |
| SG&A Expense | $17M | $20M | $22M | $19M | $14M | $11M | $11M | $12M | $16M | $14M | $17M | $18M | $21M | $18M | $18M | $13M | |
| Operating Expenses | $52M | $49M | $57M | $54M | $50M | $47M | $51M | $43M | $57M | $64M | $69M | $84M | $69M | $81M | $78M | $62M | |
| Operating Income | $-52M | $-46M | $-51M | $-51M | $-44M | $-39M | $-46M | $-40M | $-44M | $-54M | $-62M | $-82M | $-65M | $-74M | $26M | $-60M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $16M | · | $15M | $7M | $4M | · | $3M | |
| Interest Income | $5M | $5M | $6M | $4M | $4M | $4M | $4M | $5M | $6M | $7M | $7M | $7M | $3M | $2M | $493.0K | $39.0K | |
| Other Non-op | $-16M | $4M | $18M | $-7M | · | · | · | · | · | · | · | · | · | · | $2M | $0 | |
| Pretax Income | $-79M | $-53M | $-41M | $-72M | $-37M | $-43M | $-72M | $-44M | $-55M | $-65M | $-70M | $-90M | $-68M | $-78M | $7M | $-48M | |
| Income Tax | $2M | $488.0K | $-4M | $9M | $425.0K | $496.0K | $856.0K | $-31.0K | $948.0K | $656.0K | $3M | $-69.0K | $163.0K | $-1M | $-207.0K | $-329.0K | |
| Net Income | $-81M | $-54M | $-37M | $-81M | $-38M | $-44M | $-73M | $-44M | $-56M | $-66M | $-73M | $-90M | $-68M | $-77M | $7M | $-48M | |
| EPS (Basic) | $-1.22 | $-0.85 | $-0.57 | $-1.38 | $-0.69 | $-0.82 | $-1.49 | $-0.91 | $-1.16 | $-1.36 | $-1.52 | $-1.88 | $-1.44 | $-1.63 | $0.15 | $-1.02 | |
| EPS (Diluted) | $-1.22 | $-0.85 | $-0.57 | $-1.38 | $-0.69 | $-0.82 | $-1.49 | $-0.91 | $-1.16 | $-1.36 | $-1.52 | $-1.88 | $-1.44 | $-1.63 | $0.15 | $-1.02 | |
| Shares (Basic) | 66,243,879 | 62,742,847 | · | 58,516,415 | 54,807,967 | 53,110,580 | · | 48,718,533 | 48,622,440 | 48,384,510 | · | 47,770,101 | 47,649,520 | 47,436,335 | · | 46,772,430 | |
| Shares (Diluted) | 66,243,879 | 62,742,847 | · | 58,516,415 | 54,807,967 | 53,110,580 | · | 48,718,533 | 48,622,440 | 48,384,510 | · | 47,770,101 | 47,649,520 | 47,436,335 | · | 46,772,430 | |
| EBITDA | $-52M | $-46M | · | $-51M | $-44M | $-39M | · | $-40M | $-44M | $-54M | · | $-82M | $-65M | $-74M | · | $-60M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $413M | $140M | $80M | $597M | $254M | $217M | $159M | $252M | $288M | $243M | $241M | $229M | $514M | $154M | $228M | $440M | |
| Receivables | $6M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | · | · | · | · | · | · | · | · | · | $8M | · | $16M | $10M | $7M | · | $4M | |
| Prepaid Expense | $10M | $17M | $21M | $10M | $19M | $13M | $9M | $19M | $18M | $19M | · | $15M | $12M | $13M | · | $14M | |
| Current Assets | $834M | $616M | $656M | $716M | $409M | $435M | $390M | $464M | $592M | $596M | · | $694M | $757M | $443M | · | $465M | |
| PP&E (Net) | $11M | $12M | $14M | $15M | $17M | $18M | $20M | $26M | $26M | $45M | · | $46M | $49M | $50M | · | $48M | |
| PP&E (Gross) | · | · | $58M | · | · | · | $52M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $44M | $44M | $41M | $36M | $32M | $31M | $28M | $58M | · | $52M | $49M | $47M | · | $40M | |
| Goodwill | $25M | $25M | $25M | $25M | $25M | $23M | $22M | $24M | $23M | $26M | · | $25M | $26M | $26M | · | $23M | |
| Intangibles | $62M | $70M | $73M | $74M | $76M | $72M | $71M | $77M | $59M | $59M | · | $58M | $60M | $60M | · | $54M | |
| Other Non-current Assets | $5M | $6M | $6M | $5M | $5M | $5M | $1M | $1M | $5M | $5M | · | $6M | $6M | $6M | · | $6M | |
| Total Assets | $985M | $779M | $825M | $888M | $585M | $605M | $557M | $646M | $731M | $770M | · | $872M | $943M | $631M | · | $638M | |
| Accounts Payable | $5M | $4M | $5M | $6M | $6M | $5M | $7M | $5M | $4M | $5M | · | $6M | $9M | $9M | · | $8M | |
| Accrued Liabilities | $51M | $43M | $41M | $52M | $31M | $27M | $29M | $32M | $26M | $23M | · | $28M | $24M | $23M | · | $26M | |
| Current Liabilities | $83M | $59M | $63M | $101M | $41M | $36M | $40M | $71M | $80M | $63M | · | $69M | $68M | $66M | · | $64M | |
| Capital Leases | $10M | $10M | $10M | $10M | $11M | $11M | $11M | $12M | $12M | $27M | · | $29M | $30M | $31M | · | $30M | |
| Deferred Tax | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $7M | $7M | · | $5M | $7M | $7M | · | $9M | |
| Other Non-current Liabilities | $3M | $3M | $4M | $6M | $6M | $6M | $8M | $9M | $3M | $3M | · | $1M | $960.0K | $958.0K | · | $3M | |
| Total Liabilities | $661M | $629M | $626M | $660M | $589M | $572M | $563M | $590M | $634M | $623M | · | $603M | $589M | $218M | · | $217M | |
| Long-term Debt | · | · | $72M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $50M | $50M | · | $52M | $52M | $52M | · | $51M | $103M | $102M | · | $101M | $101M | $103M | · | $102M | |
| Common Stock | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Paid-in Capital | $1.84B | $1.59B | $1.58B | $1.58B | $1.26B | $1.26B | $1.17B | $1.17B | $1.16B | $1.16B | · | $1.14B | $1.13B | $1.12B | · | $1.10B | |
| Retained Earnings | $-1.46B | $-1.38B | $-1.33B | $-1.29B | $-1.21B | $-1.17B | $-1.13B | $-1.06B | $-1.01B | $-956M | · | $-817M | $-728M | $-659M | · | $-589M | |
| AOCI | $-58M | $-60M | $-58M | $-59M | $-59M | $-54M | $-53M | $-57M | $-56M | $-56M | · | $-59M | $-52M | $-52M | $-58M | $-93M | |
| Stockholders' Equity | $324M | $149M | $199M | $229M | $-4M | $34M | $-7M | $56M | $97M | $147M | $208M | $269M | $353M | $413M | $476M | $421M | |
| Liabilities + Equity | $985M | $779M | $825M | $888M | $585M | $605M | $557M | $646M | $731M | $770M | · | $872M | $943M | $631M | · | $638M | |
| Shares Outstanding | 69,334,839 | 63,033,249 | 62,336,717 | 62,165,900 | 54,865,673 | 54,698,479 | 48,988,087 | 48,738,874 | 48,694,569 | 48,492,357 | 47,833,830 | 47,810,291 | 47,702,331 | 47,546,673 | 46,968,032 | 46,815,109 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $3M | $3M | $4M | $4M | $5M | $4M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | · | $2M | |
| Stock-based Comp | $5M | $5M | $5M | $4M | $5M | $4M | $5M | $3M | $7M | $7M | $7M | $11M | $9M | $8M | $12M | $8M | |
| Deferred Tax | $2M | $500.0K | $-391.0K | $1M | $400.0K | $500.0K | $871.0K | $-120.0K | · | · | $3M | $-69.0K | $163.0K | $-1M | $-231.0K | $-329.0K | |
| Operating Cash Flow | $-29M | $-38M | $-78M | $-16M | $-40M | $-44M | $-53M | $-37M | $-33M | $-61M | $-50M | $39M | $-57M | $-78M | $-55M | $-49M | |
| CapEx | $472.0K | $140.0K | $119.0K | $-66.0K | $260.0K | $126.0K | $40.0K | $380.0K | $604.0K | $2M | $2M | $2M | $1M | $2M | $5M | $4M | |
| Investing Cash Flow | $53M | $99M | $-441M | $27M | $73M | $20M | $-27M | $48M | $78M | $64M | $60M | $-314M | $46M | $3M | $-168M | $-5M | |
| Financing Cash Flow | $249M | $550.0K | $2M | $332M | $44.0K | $81M | $-7M | $-53M | · | · | $46.0K | $-8M | $370M | $131.0K | $601.0K | $301.0K | |
| Net Change in Cash | $273M | $60M | $-517M | $343M | $37M | $58M | $-93M | $-38M | $45M | $2M | $12M | $-284M | $360M | $-74M | $-212M | $-60M | |
| Free Cash Flow | · | $-38M | · | · | · | $-44M | · | · | · | $-63M | · | · | · | $-81M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-79M | · | · | · | $-84M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -893.7% | -1283.5% | · | -1379.0% | -833.6% | -2510.0% | · | -1759.0% | -395.6% | -639.1% | · | -5819.3% | -2686.8% | -1392.9% | · | -4107.5% | |
| Net Margin | -1387.8% | -1503.0% | · | -2175.9% | -716.8% | -2784.8% | · | · | · | -773.3% | · | · | · | -1450.3% | · | · | |
| Pretax Margin | -1356.2% | -1489.2% | · | -1942.8% | -708.7% | -2753.1% | · | -1941.8% | -497.5% | -765.6% | · | -6371.0% | -2820.4% | -1472.9% | · | -3325.5% | |
| EBITDA Margin | -893.7% | -1283.5% | · | -1379.0% | -833.6% | -2510.0% | · | -1759.0% | -395.6% | -639.1% | · | -5819.3% | -2686.8% | -1392.9% | · | -4107.5% | |
| ROA | -10.3% | -7.7% | · | -10.5% | -5.7% | -6.3% | · | · | · | -9.4% | · | · | · | -11.1% | · | · | |
| ROE | -50.6% | -58.5% | · | -56.6% | -81.0% | -48.4% | · | · | · | -23.4% | · | · | · | -16.1% | · | · | |
| ROIC | -14.3% | -23.2% | · | -20.4% | -92.7% | -46.7% | · | -37.6% | -22.4% | -22.0% | · | -22.1% | -14.3% | -14.1% | · | -11.3% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 10.4 | · | 7.1 | 10.0 | 12.0 | · | 6.5 | 7.4 | 9.4 | · | 10.1 | 11.1 | 6.7 | · | 7.3 | |
| Quick Ratio | 5.0 | 2.4 | · | 5.9 | 6.2 | 6.0 | · | 3.5 | 3.6 | 3.8 | · | 3.3 | 7.5 | 2.3 | · | 6.9 | |
| Debt / Equity | 0.2 | 0.3 | · | 0.2 | -13.0 | 1.5 | · | 0.9 | 1.1 | 0.7 | · | 0.4 | 0.3 | 0.3 | · | 0.2 | |
| LT Debt / Equity | 0.2 | 0.3 | · | 0.2 | -13.0 | 1.5 | · | 0.9 | 1.1 | 0.7 | · | 0.4 | 0.3 | 0.3 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -3.4 | · | -5.3 | -9.5 | -20.8 | · | -19.4 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | · | · | · | |
| Receivables Turnover | 1.4 | 0.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.67 | $2.37 | · | $3.68 | $-0.07 | $0.62 | · | $1.15 | $1.99 | $3.03 | · | $5.62 | $7.41 | $8.68 | · | $9.00 | |
| Revenue / Share | $0.09 | $0.06 | · | $0.06 | $0.10 | $0.03 | · | $0.05 | $0.23 | $0.18 | · | $0.03 | $0.05 | $0.11 | · | $0.03 | |
| Cash Flow / Share | · | $-0.61 | · | · | · | $-0.83 | · | · | · | $-1.25 | · | · | · | $-1.65 | · | · | |
| Cash / Share | $5.96 | $2.22 | · | $9.60 | $4.63 | $3.97 | · | $5.16 | $5.91 | $5.01 | · | $4.80 | $10.77 | $3.24 | · | $9.41 | |
| EPS (TTM) | $-4.02 | $-3.49 | · | $-4.38 | $-3.91 | $-4.38 | · | $-4.95 | $-5.92 | $-6.20 | · | $-4.80 | $-3.94 | $-3.34 | · | $-2.63 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19M | $18M | · | $16M | $14M | $20M | · | $29M | $28M | $19M | · | $112M | $112M | $110M | · | $61M | |
| Net Income TTM | $-252M | $-209M | · | $-235M | $-199M | $-218M | · | $-240M | $-285M | $-297M | · | $-228M | $-187M | $-157M | · | $-125M | |
| Market Cap | $3.19B | $1.03B | · | $3.63B | $765M | $580M | · | $240M | $218M | $252M | · | $321M | $547M | $958M | · | $878M | |
| Enterprise Value | $2.83B | $941M | · | $3.08B | $563M | $414M | · | $40M | $33M | $111M | · | $193M | $134M | $907M | · | $540M | |
| P/E | -11.5 | -4.7 | · | -13.3 | -3.6 | -2.4 | · | -1.0 | -0.8 | -0.8 | · | -1.4 | -2.9 | -6.0 | · | -7.1 | |
| P/S | 171.0 | 57.0 | · | 230.4 | 53.3 | 28.7 | · | 8.4 | 7.9 | 13.3 | · | 2.9 | 4.9 | 8.7 | · | 14.3 | |
| P/B | 9.9 | 6.9 | · | 15.9 | -191.1 | 17.2 | · | 4.3 | 2.2 | 1.7 | · | 1.2 | 1.5 | 2.3 | · | 2.1 | |
| P / Tangible Book | 13.5 | 18.9 | · | 28.1 | · | · | · | · | 14.2 | 4.1 | · | 1.7 | 2.0 | 2.9 | · | 2.6 | |
| P / Cash Flow | · | -26.9 | · | · | · | -13.1 | · | · | · | -4.2 | · | · | · | -12.2 | · | · | |
| EV / Revenue | 151.6 | 52.0 | · | 195.8 | 39.3 | 20.5 | · | 1.4 | 1.2 | 5.9 | · | 1.7 | 1.2 | 8.2 | · | 8.8 | |
| Earnings Yield | -8.7% | -21.3% | · | -7.5% | -28.1% | -41.3% | · | -100.4% | -132.1% | -119.2% | · | -71.5% | -34.4% | -16.6% | · | -14.0% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $16M | $27M | $16M | $106M | $524M |
| Faaliyet Kâr Marjı % | -1151.4% | -679.6% | -1785.5% | -134.4% | 59.3% |
| Net Gelir | $-199M | $-240M | $-308M | $-127M | $330M |
| Seyreltilmiş Hisse Başı Kâr | $-3.46 | $-4.92 | $-6.47 | $-2.71 | $7.04 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.2 | -7.6 | 0.5 | 0.2 | 0.2 |
| Cari Oran | 10.4 | 9.7 | 8.8 | 6.3 | 17.1 |
| Cari Oran | 1.3 | 4.0 | 3.3 | 3.0 | 15.1 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-178M | $-186M | $-153M | $-163M | $271M |
Kurumsal Sahipler (13F) 312 dosya · $3.6B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
312
Tutulan Değer
$3.6B
Yeni pozisyonlar
98
Çıkan pozisyonlar
45
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 98 (+36 önceki Ç'ye göre) | 45 (-3 önceki Ç'ye göre) | 97 (+9 önceki Ç'ye göre) | 80 (+6 önceki Ç'ye göre) | +1.2M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Avoro Capital Advisors LLC | $309.881.409 | 6.727.777 | 8,58% | Hisse senetleri |
| JPMORGAN CHASE & CO | $230.813.250 | 4.867.755 | 6,39% | Hisse senetleri |
| RTW INVESTMENTS, LP | $181.548.806 | 3.941.572 | 5,02% | Hisse senetleri |
| STATE STREET CORP | $133.750.180 | 2.903.825 | 3,70% | Hisse senetleri |
| Aberdeen Group plc | $131.184.269 | 2.848.117 | 3,63% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $118.728.862 | 2.577.700 | 3,29% | Alım opsiyonu |
| BlackRock, Inc. | $86.475.484 | 1.877.453 | 2,39% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $83.252.805 | 1.807.486 | 2,30% | Hisse senetleri |
| Caption Management, LLC | $74.967.256 | 1.627.600 | 2,07% | Alım opsiyonu |
| JANE STREET GROUP, LLC | $74.178.847 | 1.610.483 | 2,05% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $71.918.636 | 1.561.412 | 1,99% | Hisse senetleri |
| Boxer Capital Management, LLC | $69.241.998 | 1.503.300 | 1,92% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $67.982.533 | 1.475.956 | 1,88% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $67.340.825 | 1.462.024 | 1,86% | Hisse senetleri |
| Two Seas Capital LP | $66.391.345 | 1.441.410 | 1,84% | Hisse senetleri |
| FMR LLC | $58.499.338 | 1.270.068 | 1,62% | Hisse senetleri |
| MAK CAPITAL ONE LLC | $56.748.269 | 1.232.051 | 1,57% | Hisse senetleri |
| MPM BIOIMPACT LLC | $56.462.881 | 1.225.855 | 1,56% | Hisse senetleri |
| MORGAN STANLEY | $49.129.407 | 1.066.639 | 1,36% | Hisse senetleri |
| CITADEL ADVISORS LLC | $46.069.212 | 1.000.200 | 1,27% | Alım opsiyonu |
| Vestal Point Capital, LP | $43.066.100 | 935.000 | 1,19% | Hisse senetleri |
| MAVERICK CAPITAL LTD | $42.623.141 | 925.383 | 1,18% | Hisse senetleri |
| CITADEL ADVISORS LLC | $41.930.168 | 910.338 | 1,16% | Hisse senetleri |
| Fiera Capital Corp | $41.875.034 | 909.141 | 1,16% | Hisse senetleri |
| Integral Health Asset Management, LLC | $41.454.000 | 900.000 | 1,15% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $39.658.136 | 860.631 | 1,10% | Hisse senetleri |
| Longaeva Partners L.P. | $37.059.600 | 804.594 | 1,03% | Hisse senetleri |
| Nantahala Capital Management, LLC | $36.848.000 | 800.000 | 1,02% | Alım opsiyonu |
| VANGUARD CAPITAL MANAGEMENT LLC | $35.916.621 | 779.779 | 0,99% | Hisse senetleri |
| CITIGROUP INC | $30.629.900 | 665.000 | 0,85% | Alım opsiyonu |
| Invesco Ltd. | $28.917.526 | 627.823 | 0,80% | Hisse senetleri |
| First Turn Management, LLC | $28.047.086 | 608.925 | 0,78% | Hisse senetleri |
| Point72 Asset Management, L.P. | $27.922.125 | 606.212 | 0,77% | Hisse senetleri |
| CITADEL ADVISORS LLC | $27.484.002 | 596.700 | 0,76% | Satım opsiyonu |
| Balyasny Asset Management L.P. | $27.017.967 | 586.582 | 0,75% | Hisse senetleri |
| Kinetic Partners Management, LP | $26.760.860 | 581.000 | 0,74% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $26.658.884 | 578.786 | 0,74% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $26.571.872 | 1.110.400 | 0,74% | Hisse senetleri |
| 683 Capital Management, LLC | $26.484.501 | 575.000 | 0,73% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $25.254.698 | 548.300 | 0,70% | Alım opsiyonu |
| JANE STREET GROUP, LLC | $25.231.668 | 547.800 | 0,70% | Alım opsiyonu |
| VANGUARD GROUP INC | $25.159.500 | 1.051.379 | 0,70% | Hisse senetleri |
| GILDER GAGNON HOWE & CO LLC | $24.456.893 | 530.979 | 0,68% | Hisse senetleri |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | $24.028.443 | 521.677 | 0,66% | Hisse senetleri |
| Assenagon Asset Management S.A. | $23.653.192 | 513.530 | 0,65% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22.887.076 | 496.897 | 0,63% | Hisse senetleri |
| UBS Group AG | $21.536.321 | 467.571 | 0,60% | Hisse senetleri |
| Nantahala Capital Management, LLC | $20.987.700 | 455.660 | 0,58% | Hisse senetleri |
| Voss Capital, LP | $20.743.628 | 450.361 | 0,57% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $19.349.806 | 420.100 | 0,54% | Satım opsiyonu |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Coller Investment Management Limited, Coller International General Partner V, L.P, Coller International Partners V-A, L.P ×4 başvurular | 03 Nisan 2019 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 28 içeriden öğrenenler · 17 yöneticiler · 12 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Matthew C Kapusta | CEO, Managing Director | 02 Temmuz 2026 M | 519.227 | 0 | 16 | $-12.864.927 |
| Christian Klemt | Chief Financial Officer | 04 Mart 2026 A | 226.581 | 0 | 3 | $-381.751 |
| Ricardo Dolmetsch | President, R&D | 18 Eylül 2023 S | 163.404 | 0 | 0 | $0 |
| Pierre Caloz | Chief Operating Officer | 17 Haziran 2024 S | 115.707 | 0 | 0 | $0 |
| Scott T. Mcmillan | Chief Operating Officer | 28 Ocak 2019 S | 20.432 | 0 | 0 | $0 |
| Walid Abi-Saab | Chief Medical Officer | 30 Haziran 2026 M | 148.235 | 0 | 7 | $-2.611.134 |
| Jeannette Potts | Chief Legal Officer | 15 Haziran 2026 S | 133.246 | 0 | 3 | $-261.172 |
| Kylie O'Keefe | Chief Customer & Strat Officer | 11 Haziran 2026 S | 108.864 | 0 | 1 | $-431.228 |
| Alexander Edward Kuta III | Executive VP, Operations | 07 Mart 2023 S | 90.381 | 0 | 0 | $0 |
| Sander Van Deventer | EVP, Research & Product Dev. | 27 Şubat 2020 A | 61.599 | 0 | 0 | $0 |
| Steven Zelenkofske | Chief Medical Officer | 06 Haziran 2018 S | 159.458 | 0 | 0 | $0 |
| Jonathan Garen | Chief Business Officer | 26 Ocak 2018 A | 93.638 | 0 | 0 | $0 |
| Paul E Firuta | Chief Commercial Officer | 26 Ocak 2018 A | 93.817 | 0 | 0 | $0 |
| Maria E Cantor | SVP, Investor Rel. & Comm. | 26 Ocak 2018 A | 92.439 | 0 | 0 | $0 |
| Harald Petry | Chief Scientific Officer | 29 Haziran 2017 M | 0 | 0 | 0 | $0 |
| Christian Meyer | Chief Medical Officer | 27 Ocak 2017 A | · | 0 | 0 | $0 |
| Maiken Keson-Brookes | General Counsel | 27 Ocak 2017 A | · | 0 | 0 | $0 |
| Jack Kaye | Yönetim kurulu üyesi | 30 Haziran 2026 M | 25.996 | 0 | 9 | $-2.693.581 |
| Madhavan Balachandran | Yönetim kurulu üyesi | 17 Haziran 2026 M | 43.254 | 0 | 5 | $-858.916 |
| Rachelle Suzanne Jacques | Yönetim kurulu üyesi | 10 Haziran 2026 A | 33.903 | 0 | 1 | $-53.931 |
| Jeremy P. Springhorn | Yönetim kurulu üyesi | 10 Haziran 2026 A | 43.251 | 0 | 1 | $-53.931 |
| Robert Gut | Yönetim kurulu üyesi | 10 Haziran 2026 A | 32.259 | 0 | 9 | $-1.757.850 |
| David D. Meek | Yönetim kurulu üyesi | 10 Haziran 2026 A | 39.747 | 0 | 1 | $-53.931 |
| Leonard E Post | Yönetim kurulu üyesi | 10 Haziran 2026 A | 35.494 | 0 | 1 | $-53.931 |
| Paula Soteropoulos | Yönetim kurulu üyesi | 13 Haziran 2024 S | 20.203 | 0 | 0 | $0 |
| Philip Astley-Sparke | Yönetim kurulu üyesi | 02 Mart 2021 S | 9.946 | 0 | 0 | $0 |
| David Schaffer | Yönetim kurulu üyesi | 27 Şubat 2020 A | 46.978 | 0 | 0 | $0 |
| William Lewis | Yönetim kurulu üyesi | 27 Ocak 2017 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 12 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1,06% | 131.294 SH | 02 Ekim 2026 | Günlük |
| LABU · Direxion Shares ETF Trust | 0,72% | 81.217 NS | 31 Temmuz 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,34% | 58.938 SH | 02 Ekim 2026 | Günlük |
| IBB · iShares Trust | 0,21% | 492.076 SH | 11 Eylül 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,11% | 4.906 SH | 02 Ekim 2026 | Günlük |
| ESML · iShares Trust | 0,05% | 30.024 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 757.841 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,03% | 141.093 SH | 19 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,02% | 2.657 SH | 11 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,00% | 89.136 SH | 11 Eylül 2026 | Günlük |
| ISCB · iShares Trust | · | 2.897 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 14.325 SH | 11 Eylül 2026 | Günlük |
QURE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 20 analist
AL
Medyan hedef
$69.54
+196,4%
7 35,0%
Güçlü Al
11 55,0%
Al
2 10,0%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
11 analist · 2026-10-03Ortalama hedef $65.48 +179,1%
← Tüm hedeflerin altında
Mevcut fiyat $23.46
Düşük$30.80
Ortalama$65.48
Yüksek$91.95
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Tem 29, 2026